Akebia Therapeutics | AKBA - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Ardelyx USD 31.21M 36.79M 2026-03
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 5.9B 1.34B 2025-09
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Exelixis USD 482.49M 106.19M 2025-12
Fresenius Medical Care EUR 1.58B 326.57M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
J&J USD 21.69B 1.98B 2026-03
Kangmei Pharma CNY 1.18B 278M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 1.91B 687M 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pharma Mar EUR 48.86M 31.05M 2026-03
Prothena USD 307.53M 23.31M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Qiagen NV USD 839M 516.58M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Tilray USD 264.83M 43.16M 2025-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03